| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT03862430 A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly… |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-08-07 | NCT03862430 A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly… |
date change Completion pushed: 2026-09-30 -> 2027-09-30 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-05 | NCT07748299 NuvOx Expanded Access | Available |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT03862430 | A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly… | Glioblastoma Multiforme | Active, Not Recruiting |
| Phase 1 | |||
| NCT06658535 | A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress | Mild Respiratory Distress | Recruiting |
| Not specified | |||
| NCT07417774 | Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic | Glioblastoma (GBM) | Enrolling by Invitation |